Laurent Attias
Senior Vice President, Head of Strategy, BD&L and Market Access, Alcon, USA
Leonard Borrmann
Head of External Innovation, Johnson & Johnson Surgical Vision, Inc., USA
Malvina Eydelman
Director, Office of Ophthalmic, Anesthesia, Respiratory, ENT & Dental Devices, Food & Drug Administration, Government, USA
Michael Giaquinto
Senior Managing Director, SVB Leerink, USA
Rafiq Hasan
Global Head, Ophthalmology, Bayer AG, Germany
Chuck Hess
Vice President & General Manager, US Surgical, Bausch+Lomb, USA
Eugene de Juan
Founder & Managing Partner, ForSight Labs, Menlo Park, USA
Greg Kunst
Vice President, Global Marketing, Glaukos Inc., San Clemente, USA
Akira Kurokawa
Chief Executive Officer and President, Santen Pharmaceutical Co. Ltd., Osaka, Japan
Jim Mazzo
Executive Chairman, Neurotech
Michael J. O’Rourke
Chief Executive Officer, Re-Vana Therapeutics, Inc., Belfast, UK
Ram Palanki
Senior Vice President, Commercial Strategy & Operations, REGENXBIO, Inc., USA
Dirk Sauer
Global Development Unit Head Ophthalmology, Novartis, Basel, Switzerland
Brent Saunders
Chief Executive Officer and President, Allergan Inc., Dublin, Ireland
Baldo Scasselati Sforzolini
Senior Vice President, Drug Development Operations and Evidence & Value, Allergan Inc., Dublin, Ireland
Naveed Shams
Chief Scientific Officer and Executive Fellow, Santen Pharmaceutical Co. Ltd., Osaka, Japan
Naveed Siddiqi
Partner, Novo Ventures, Novo Holdings A/S, Hellerup, Denmark
Ramin Valian
Vice President, Interventional Glaucoma, Reimbursement and Pipeline-US, Allergan, Inc., USA